FBC
LLY icon

Fairfield, Bush & Co’s Eli Lilly LLY Stock Holding History

Fairfield, Bush & Co’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.61M Sell
2,837
-4
-0.1% -$4.05K 1.45% 21
2025
Q4 		$3.05M Sell
2,841
-115
-4% -$110K 1.61% 14
2025
Q3 		$2.26M Buy
2,956
+131
+5% +$97.5K 1.16% 25
2025
Q2 		$2.2M Buy
2,825
+74
+3% +$57.5K 1.24% 25
2025
Q1 		$2.27M Buy
2,751
+30
+1% +$25K 1.44% 19
2024
Q4 		$2.1M Sell
2,721
-5
-0.2% -$4.14K 1.24% 22
2024
Q3 		$2.42M Buy
2,726
+425
+18% +$382K 1.44% 19
2024
Q2 		$2.08M Buy
2,301
+162
+8% +$130K 1.25% 23
2024
Q1 		$1.66M Buy
2,139
+24
+1% +$17.1K 0.99% 31
2023
Q4 		$1.23M Buy
2,115
+194
+10% +$113K 0.72% 36
2023
Q3 		$1.03M Sell
1,921
-24,555
-93% -$12.7M 0.67% 39
2023
Q2 		$12.4M Sell
26,476
-231
-0.9% -$96.9K 3.42% 6
2023
Q1 		$9.17M Buy
26,707
+25,080
+1,541% +$8.46M 3.23% 6
2022
Q4 		$595K Buy
1,627
+635
+64% +$225K 0.39% 55
2022
Q3 		$321K Buy
992
+587
+145% +$186K 0.23% 85
2022
Q2 		$131K Buy
+405
New +$122K 0.08% 132
2021
Q4 		– Sell
-3,000
Closed -$693K – 150
2021
Q3 		$693K Sell
3,000
-21,325
-88% -$5.26M 0.23% 94
2021
Q2 		$5.58M Hold
24,325
– – 1.52% 18
2021
Q1 		$4.54M Hold
24,325
– – 1.3% 20
2020
Q4 		$4.11M Sell
24,325
-25
-0.1% -$3.73K 1.2% 24
2020
Q3 		$3.6M Hold
24,350
– – 1.15% 23
2020
Q2 		$4M Sell
24,350
-250
-1% -$38.4K 1.43% 15
2020
Q1 		$3.41M Hold
24,600
– – 1.42% 19
2019
Q4 		$3.23M Hold
24,600
– – 1.19% 23
2019
Q3 		$2.75M Sell
24,600
-50
-0.2% -$5.57K 0.95% 30
2019
Q2 		$2.73M Hold
24,650
– – 0.93% 27
2019
Q1 		$3.2M Hold
24,650
– – 1.06% 27
2018
Q4 		$2.85M Hold
24,650
– – 0.98% 27
2018
Q3 		$2.65M Hold
24,650
– – 0.74% 32
2018
Q2 		$2.1M Sell
24,650
-500
-2% -$41.1K 0.62% 40
2018
Q1 		$1.95M Buy
25,150
+500
+2% +$40.3K 0.57% 44
2017
Q4 		$2.08M Hold
24,650
– – 0.57% 42
2017
Q3 		$2.11M Hold
24,650
– – 0.66% 39
2017
Q2 		$2.03M Sell
24,650
-63
-0.3% -$5.14K 0.65% 40
2017
Q1 		$2.08M Buy
24,713
+200
+0.8% +$16K 0.65% 38
2016
Q4 		$1.8M Hold
24,513
– – 0.59% 43
2016
Q3 		$1.97M Hold
24,513
– – 0.64% 37
2016
Q2 		$1.93M Hold
24,513
– – 0.67% 40
2016
Q1 		$1.76M Hold
24,513
– – 0.63% 40
2015
Q4 		$2.06M Buy
24,513
+24,000
+4,678% +$1.99M 0.72% 43
2015
Q3 		$43K Sell
513
-23,737
-98% -$2M 0.02% 132
2015
Q2 		$2.02M Hold
24,250
– – 0.61% 47
2015
Q1 		$1.76M Hold
24,250
– – 0.51% 53
2014
Q4 		$1.67M Hold
24,250
– – 0.48% 54
2014
Q3 		$1.57M Hold
24,250
– – 0.45% 54
2014
Q2 		$1.51M Buy
24,250
+24,000
+9,600% +$1.43M 0.44% 58
2014
Q1 		$15K Hold
250
– – 0.01% 125
2013
Q4 		$13K Sell
250
-24,250
-99% -$1.21M 0.01% 123
2013
Q3 		$1.23M Hold
24,500
– – 0.37% 62
2013
Q2 		$1.2M Buy
+24,500
New +$1.33M 0.61% 44

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fairfield, Bush & Co's LLY Position: Q1 2026 in Review

Fairfield, Bush & Co reduced its Eli Lilly (LLY) stake by 0.14% in Q1 2026, selling an estimated $4.05K and leaving 2,837 shares worth $2.61M. The position accounts for 1.45% of the portfolio, ranked #21.

Fairfield, Bush & Co first reported a position in LLY in Q2 2013 and has held it in 50 quarters since. The position peaked at $12.4M in Q2 2023. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fairfield, Bush & Co held 2,837 shares of Eli Lilly worth $2.61M as of Q1 2026.
  • Fairfield, Bush & Co sold 4 Eli Lilly shares in Q1 2026, an estimated $4.05K.
  • Eli Lilly made up 1.45% of Fairfield, Bush & Co's portfolio in Q1 2026, its #21 holding.
  • Fairfield, Bush & Co first reported a position in Eli Lilly in Q2 2013 and has held it in 50 quarters since.
  • Fairfield, Bush & Co's Eli Lilly position peaked at $12.4M in Q2 2023.
  • 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fairfield, Bush & Co's 13F filing for Q1 2026, filed 12 May 2026.